Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Sensitive aHUS

NCT00844428 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

Atypical Hemolytic Uremic Syndrome

Interventions

DRUG: eculizumab

Sponsor

Alexion Pharmaceuticals, Inc.